Evidence map›Paper›PMID 32533093›Full record

ArticleLeukemia2020

Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols.

Alexander Popov, Barbara Buldini, Paola De Lorenzo, Silvia Disarò, Tatiana Verzhbitskaya, Liudmila Movchan, Emanuela Giarin, Egor Shorikov, Annamaria Di Meglio, Grigory Tsaur and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Clinical Implications of Minimal Residual Disease Detection in Infants WithJournal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Alexander Popov *National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation. uralcytometry@gmail.com.ORCID http://orcid.org/0000-0002-0889-6986
Barbara Buldini *Dipartimento di Salute della Donna e del Bambino, University of Padua, Padua, Italy.
Paola De LorenzoInterfant Trial Data Center, School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Silvia DisaròFondazione Città della Speranza - Onlus, Dipartimento di Salute della Donna e del Bambino, University of Padova, Padova, Italy.
Tatiana VerzhbitskayaRegional Children Hospital, Ekaterinburg, Russian Federation.
Liudmila MovchanBelarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Emanuela GiarinFondazione Città della Speranza - Onlus, Dipartimento di Salute della Donna e del Bambino, University of Padova, Padova, Italy.
Egor ShorikovPET-Technology Center of Nuclear Medicine, Ekaterinburg, Russian Federation.
Annamaria Di MeglioFondazione Città della Speranza - Onlus, Dipartimento di Salute della Donna e del Bambino, University of Padova, Padova, Italy.
Grigory TsaurRegional Children Hospital, Ekaterinburg, Russian Federation.ORCID http://orcid.org/0000-0002-9881-6221
Rosanna ParasoleDepartment of Pediatric Hemato-Oncology, Santobono-Pausilipon Hospital, Naples, Italy.
Natalia MiakovaNational Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Elmira BoichenkoCity Children's Hospital №1, Saint-Petersburg, Russian Federation.
Konstantin KondratchikMorozov Children's Hospital, Moscow, Russian Federation.
Olga AleinikovaBelarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Alexander KarachunskiyNational Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Alexander RoumiantsevNational Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Franco LocatelliDepartment of Pediatric Hematology and Oncology, Scientific Institute for Research and Healthcare (IRCCS), Bambino Gesù Children's Hospital, Rome, Italy.
Andrea BiondiTettamanti Research Center, Pediatric Clinic, University of Milan-Bicocca, Fondazione MBBM/ S. Gerardo Hospital Monza, Monza, Italy.
Rob PietersPrincess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Maria Grazia ValsecchiInterfant Trial Data Center, School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Larisa FechinaRegional Children Hospital, Ekaterinburg, Russian Federation.
Giuseppe BassoDipartimento di Salute della Donna e del Bambino, University of Padua, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Flow CytometryAntineoplastic Combined Chemotherapy ProtocolsBone MarrowFemaleHumansIncidenceInfantMaleNeoplasm, ResidualPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisRecurrenceSurvival AnalysisTreatment Outcome

Identifiers

PMID32533093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.